Home > Boards > US OTC > Medical - Healthcare > HealthLynked Corp (HLYK)

Question for investors here. I see

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
quito_yume Member Profile
 
Followed By 0
Posts 40
Boards Moderated 0
Alias Born 04/14/19
160x600 placeholder
Notice of Effectiveness (effect) Edgar (US Regulatory) - 6/25/2019 6:01:18 AM
Post-effective Amendment to Registration Statement (pos Am) Edgar (US Regulatory) - 6/20/2019 2:43:07 PM
Post-effective Amendment to Registration Statement (pos Am) Edgar (US Regulatory) - 6/17/2019 5:18:02 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/15/2019 4:26:20 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/6/2019 4:04:14 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/18/2019 3:45:44 PM
Annual Report (10-k) Edgar (US Regulatory) - 4/1/2019 3:15:34 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/29/2019 6:19:09 AM
Founder Former Chairman & CEO of $1.5 Billion NeoGenomics, Dr. Michael Dent, Now Leading HealthLynked in Mushrooming $142 Bill InvestorsHub NewsWire - 3/25/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/22/2019 4:09:40 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/14/2018 3:39:37 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 8/23/2018 3:37:57 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 8/23/2018 6:07:51 AM
Securities Registration Statement (s-1) Edgar (US Regulatory) - 8/16/2018 12:48:33 PM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 8/16/2018 6:06:16 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/14/2018 4:45:42 PM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 7/26/2018 9:16:45 AM
quito_yume   Sunday, 04/14/19 05:54:42 PM
Re: None
Post # of 1764 
Question for investors here. I see they want to do a NASDAQ upgrade in the next 12-18 months.. Sounds good on the surface but how are they going to get there? What I've seen in the past is that if some companies are not able to get the share price up to => $1 organically then they do a reverse split to force it, often followed by additional shelf offerings to raise capital. So there are both of those forces in play for the future, a RS and an offering that has the potential to be a big dilution. Anybody see a way around these possible scenarios? Also, for what it's worth for the time being it appears the stock price is priced at pretty much exactly what the company is worth, imo. Thx !

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist